Murine model for non-IgE-mediated asthma

Inflammation. 2004 Jun;28(3):115-25. doi: 10.1023/b:ifla.0000039557.33267.65.

Abstract

There is increasing evidence that inflammatory mechanisms other than atopy or eosinophilic inflammation may be involved in the pathogenesis of asthma. The mechanisms associated with non-atopic (non-IgE) or neutrophil-mediated asthma are poorly investigated. Non-atopic airway inflammation and hyperresponsiveness was induced in mice by skin sensitization with dinitrofluorobenzene (DNFB) followed by intra-airway challenge with dinitrobenzene sulfonic acid (DNS). Acute bronchoconstriction and mast cell activation were observed shortly after challenge. Increased levels of the major mast cell mediator, TNF-alpha, were found in the bronchoalveolar lavage fluid of DNFB-sensitized. Mast cells play a key role in the early release of TNF-alpha since mast-cell-deficient WBB6F1-W/Wv mice did not show an increase in TNF-alpha release after DNFB-sensitization and DNS challenge compared to their ++ littermates. Features of the late-phase pulmonary reaction included mononuclear and neutrophilic cell infiltration, pulmonary edema, in vitro tracheal hyperreactivity and in vivo airway hyperresponsiveness. These characteristics bear marked similarity with those observed in non-atopic asthmatic patients. Therefore, this model can be used to further study the mechanisms potentially responsible for the development of non-IgE-mediated asthma.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma / chemically induced*
  • Asthma / immunology*
  • Asthma / physiopathology
  • Carbachol / pharmacology
  • Dermatitis, Contact / immunology
  • Dermatitis, Contact / physiopathology
  • Dinitrofluorobenzene / toxicity
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Immunoglobulin E* / physiology
  • Lung / drug effects
  • Lung / immunology
  • Male
  • Mice
  • Mice, Inbred BALB C

Substances

  • Immunoglobulin E
  • Carbachol
  • Dinitrofluorobenzene